About Letbo
Letbo is a publicly listed company based in Taipei (Taiwan) founded in 2019. It operates as an automated nucleic acid detection systems and reagents are developed. Its chief executive is Chi Sheng Tai. Letbo offers products and services including Automated Nucleic Acid Detection System and Nucleic Acid Extraction Reagents. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Genomics. Its legal entity in India is εηΉεηζθ‘δ»½ζιε ¬εΈ (U99999MH1977PLC010754).
Company details
Letbo was founded in 2019 in Taipei, Taiwan, within the biotechnology sector. Automated systems for nucleic acid detection are provided to support pathogen and genetic marker identification in clinical diagnostics and research settings. Efficiency and accuracy are improved while human error is minimized, yielding consistent outcomes. Reagents for high-purity RNA and DNA extraction from diverse samples are supplied, alongside high-sensitivity options for targeted pathogen and gene testing.
- Headquarters Taipei, Taiwan
- Stage Public
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website labturbo.com.tw
- Legal Name Labturbo Biotech Corporation
- Annual Revenue$79.07 M8.35as on Dec 31, 2025
- Net Profit-$131.54 M-1114.72as on Dec 31, 2025
- EBITDA-$143.41 M-8.54as on Dec 31, 2025
Associated legal entities of Letbo
Letbo operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | – | – | – | View details |
Products & Services of Letbo
Letbo offers a comprehensive portfolio of products and services, including Automated Nucleic Acid Detection System and Nucleic Acid Extraction Reagents.
Automated systems are utilized for efficient detection of pathogens and genetic markers, reducing errors in clinical diagnostics and research applications
Reagents are employed for high-purity extraction of RNA and DNA from various samples, ensuring integrity for downstream analyses in diagnostics and studies
People of Letbo
1 people are tracked at Letbo (1 in leadership).
| Name | Role | Group |
|---|---|---|
Chi Sheng Tai | CEO | Leadership |
Complete people profiles for Letbo
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Letbo
Letbo is a publicly listed company on the TPEX with ticker symbol 7725 in Taiwan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date22 Dec 2023
- Listed onTT: 7725
- Listed entityLabTurbo Biotech Corporation
- Exchange sectorHealth technology
- ISINTW0007725004
- Share price23.00 TWD · 2026-10-13
- Market capitalisation1,102,657,559.00 TWD
- EPS (diluted, trailing year)-0.82 TWD
- Dividend yield0.87%
- Volume (last session)1,000
Financials of Letbo
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 79.1M TWD | -131.5M TWD | -143.4M TWD |
| 2024 | 73.0M TWD | 13.0M TWD | -132.1M TWD |
| 2023 | 188.1M TWD | -64.3M TWD | -135.6M TWD |
| 2022 | 1.34B TWD | 642.8M TWD | 840.0M TWD |
| 2021 | 979.5M TWD | 458.5M TWD | 604.4M TWD |
Balance sheet, profit and loss, cash flow and ratios of , are on its company page.
Detailed financial statements for Letbo
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Letbo (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Letbo
Letbo was founded in 2019.
Letbo is headquartered in Taipei, Taiwan.
Chi Sheng Tai is the current CEO of Letbo.
Letbo was founded in 2019 in Taipei, Taiwan, within the biotechnology sector. Automated systems for nucleic acid detection are provided to support pathogen and genetic marker identification in clinical diagnostics and research settings. Efficiency and accuracy are improved while human error is minimized, yielding consistent outcomes. Reagents for high-purity RNA and DNA extraction from diverse samples are supplied, alongside high-sensitivity options for targeted pathogen and gene testing.
Letbo offers Automated Nucleic Acid Detection System and Nucleic Acid Extraction Reagents.
Yes, Letbo is publicly traded on TPEX under the ticker symbol 7725.
Letbo operates through ,.